Women'’'s experiences and perceptions, both positive and negative, can affect the way they will react to provider-initiated attempts to screen and assess them for PPD. Click on the following links to learn more about the most common provider-oriented and patient-oriented barriers to screening and assessing women with PPD, with suggestions for circumventing each set of barriers.
The following chart presents some of the most common patient-oriented barriers to screening and assessing women with PPD, with suggestions for circumventing each set of barriers.
Common Patient-Oriented Barriers and Solutions 53
Common Provider-Oriented Barriers and Solutions
For more information on barriers to screening and assessing PPD in these specific subpopulations, click on each group name below:
- Adolescents 10 18
- African American women 4
- Asian/Pacific Islander and Asian American women 65 109 123 141 142
- Latina/Hispanic women 8 32
- Middle Eastern, Arab, and Arab American women 101 115 122 129
- Women in rural areas 72 83 106 128 131
- Women with prior infertility and/or who have conceived via assisted reproductive technologies (ART) or women who delivered multiples 49 70 93
- Women whose infants were hospitalized after birth 41 133
Even the best intentioned providers may unwittingly present barriers to accurately detecting and assessing PPD in practice. Determine if you have experienced any of these common provider-oriented barriers 35 to screening and assessment, and learn ways to overcome these barriers and enhance your skills in this area.